ARTICLE | Clinical News
Agouron regulatory update
August 17, 1998 7:00 AM UTC
AGPH received Canadian marketing approval for its Viracept HIV protease inhibitor to treat HIV infection in adults and children in combination with reverse transcriptase inhibitors. ...